Biohaven Ltd. (BHVN)
US Market

Biohaven Ltd. (BHVN) Stock Price & Analysis


BHVN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$8.25 - $27.40
Previous Close$23.22
Average Volume (3M)1.04M
Market Cap
Enterprise Value$1.22B
Total Cash (Recent Filing)$449.58M
Total Debt (Recent Filing)$29.76M
Price to Earnings (P/E)-3.7
Nov 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.32
Shares Outstanding68,317,078
10 Day Avg. Volume1,643,802
30 Day Avg. Volume1,039,514
Standard Deviation0.51
Financial Highlights & Ratios
Price to Book (P/B)4.02
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-5.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-9.06
Price Target Upside15.20% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Biohaven Ltd.’s price range in the past 12 months?
Biohaven Ltd. lowest stock price was $8.25 and its highest was $27.40 in the past 12 months.
    What is Biohaven Ltd.’s market cap?
    Currently, no data Available
    When is Biohaven Ltd.’s upcoming earnings report date?
    Biohaven Ltd.’s upcoming earnings report date is Nov 08, 2023 which is in 35 days.
      How were Biohaven Ltd.’s earnings last quarter?
      Biohaven Ltd. released its earnings results on Jul 31, 2023. The company reported -$1.32 earnings per share for the quarter, missing the consensus estimate of -$1.182 by -$0.138.
        Is Biohaven Ltd. overvalued?
        According to Wall Street analysts Biohaven Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Biohaven Ltd. pay dividends?
          Biohaven Ltd. does not currently pay dividends.
          What is Biohaven Ltd.’s EPS estimate?
          Biohaven Ltd.’s EPS estimate is -$1.34.
            How many shares outstanding does Biohaven Ltd. have?
            Biohaven Ltd. has 68,317,080 shares outstanding.
              What happened to Biohaven Ltd.’s price movement after its last earnings report?
              Biohaven Ltd. reported an EPS of -$1.32 in its last earnings report, missing expectations of -$1.182. Following the earnings report the stock price went up 4.357%.
                Which hedge fund is a major shareholder of Biohaven Ltd.?
                Among the largest hedge funds holding Biohaven Ltd.’s share is Farallon Capital Management, L.L.C.. It holds Biohaven Ltd.’s shares valued at 18M.


                  Biohaven Ltd. Stock Smart Score

                  The Biohaven Ltd. stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Biohaven Ltd.

                  Biohaven Ltd is a commercial-stage biopharmaceutical company with a portfolio of innovative therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including rare disorders. Biohaven's Neuroinnovation portfolio includes FDA-approved Nurtec ODT (rimegepant) for the acute and preventive treatment of migraine (EMA-approved as Vydura (rimegepant) for the acute treatment of migraine with or without aura, and prophylaxis of episodic migraine.


                  Top 5 ETFs holding BHVN

                  Market Value
                  Smart Score
                  Vanguard Health Care ETF
                  Schwab U.S. Broad Market ETF
                  iShares Russell 3000 ETF
                  Vanguard U.S. Momentum Factor ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold BHVN. The ETFs are listed according to market value of BHVN within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Apellis Pharmaceuticals
                  Assertio Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis